Biolase Total Assets 2010-2023 | BIOL

Biolase total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
Biolase Annual Total Assets
(Millions of US $)
2022 $38
2021 $55
2020 $41
2019 $32
2018 $39
2017 $43
2016 $42
2015 $42
2014 $59
2013 $31
2012 $32
2011 $30
2010 $18
2009 $22
Biolase Quarterly Total Assets
(Millions of US $)
2023-09-30 $39
2023-06-30 $40
2023-03-31 $42
2022-12-31 $38
2022-09-30 $43
2022-06-30 $51
2022-03-31 $50
2021-12-31 $55
2021-09-30 $59
2021-06-30 $61
2021-03-31 $63
2020-12-31 $41
2020-09-30 $42
2020-06-30 $28
2020-03-31 $25
2019-12-31 $32
2019-09-30 $28
2019-06-30 $32
2019-03-31 $34
2018-12-31 $39
2018-09-30 $34
2018-06-30 $36
2018-03-31 $40
2017-12-31 $43
2017-09-30 $37
2017-06-30 $42
2017-03-31 $37
2016-12-31 $42
2016-09-30 $45
2016-06-30 $36
2016-03-31 $38
2015-12-31 $42
2015-09-30 $47
2015-06-30 $51
2015-03-31 $55
2014-12-31 $59
2014-09-30 $30
2014-06-30 $26
2014-03-31 $29
2013-12-31 $31
2013-09-30 $33
2013-06-30 $32
2013-03-31 $31
2012-12-31 $32
2012-09-30 $29
2012-06-30 $28
2012-03-31 $28
2011-12-31 $30
2011-09-30 $29
2011-06-30 $30
2011-03-31 $20
2010-12-31 $18
2010-09-30 $19
2010-06-30 $20
2010-03-31 $20
2009-12-31 $22
2009-09-30 $23
2009-06-30 $22
2009-03-31 $22
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.003B $0.048B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.833B 20.28
McKesson (MCK) United States $68.227B 18.26
Cardinal Health (CAH) United States $26.821B 16.12
West Pharmaceutical Services (WST) United States $26.629B 44.96
Align Technology (ALGN) United States $23.807B 47.17
Cooper (COO) United States $18.781B 29.53
Labcorp (LH) United States $18.293B 15.48
Henry Schein (HSIC) United States $10.469B 15.95
DENTSPLY SIRONA (XRAY) United States $7.138B 18.21
Merit Medical Systems (MMSI) United States $4.607B 26.68
Patterson (PDCO) United States $2.683B 12.27
CONMED (CNMD) United States $2.463B 23.21
STAAR Surgical (STAA) United States $1.550B 48.85
Atrion (ATRI) United States $0.623B 29.29
Lifevantage (LFVN) United States $0.090B 14.54
Pro-Dex (PDEX) United States $0.060B 22.67